ABVX — Abivax SA Cashflow Statement
0.000.00%
Last trade - 00:00- €366.78m
- €311.20m
Annual cashflow statement for Abivax SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | FAS | FAS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38 | -41.4 | -60.7 | -148 | -176 |
| Depreciation | |||||
| Non-Cash Items | -1.55 | 0.635 | 8.32 | 28.6 | 19.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 9.67 | -4.99 | -2 | 21.3 | 1.43 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -29.8 | -45.6 | -53.9 | -97.1 | -154 |
| Capital Expenditures | -0.898 | -0.047 | -0.323 | -0.265 | -0.643 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.323 | -1.53 | -11.7 | -7.83 | 16.4 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.575 | -1.57 | -12 | -8.1 | 15.8 |
| Financing Cash Flow Items | 0 | — | -4.45 | -34.6 | -11 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 49.9 | 78.5 | 32.2 | 335 | 28.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.5 | 31.4 | -33.8 | 225 | -108 |